DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Sonder Capital Management, LLC
Sonder Capital Management, LLC
Sonder Capital invests in teams and technologies that can transform healthcare in the medical device, diagnostic and healthtech sectors. We are Foundational Investors – we commit our energy and capital early to guide and support companies from inception to acquisition or IPO. We look for big ideas that will change lives.
venture manager, reported GAV $139M across 12 vehicles
Importance
38
elevated
Active deployment
29
moderate
Emerging
0
low
Completeness
88
high
Freshness
100
high
Research priority
10
low
Identity and regulatory footprint
- Headquarters
- San Carlos, CAadviserinfo.sec.gov
- Office address
- 661 EL CAMINO REAL #202, San Carlos, CA, 94070adviserinfo.sec.gov
- Business phone
- 650-464-1368adviserinfo.sec.gov
- Website
- https://sondercapital.com/
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 30, 2026
- Private funds reported
- 8 (8 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $151Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business email
- closethegap@sondercapital.comsondercapital.compublished by the subject
- business email
- info@sondercapital.comsondercapital.compublished by the subject
- business phone
- 203-981-6526adviserinfo.sec.govpublished by the subject
- business phone
- 650-464-1368adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
4 observed deals
Stated (the firm’s website)
- Sectors
- healthcare, medtech, energy
- Stages
- early
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation
seed 100%
Stage at first entry
seed 100%
Sectors
Other 25%unknown 25%Biotechnology 25%Other Health Care 25%
lead rate 100%follow-on rate 0%new logos, 12 months 1
Funds and vehicles
12 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Sonder SPV J Series B, LP | SPV or co-invest vehicle | 2025 form d first sale | Newly closed | unknown | unknown | $4.2M of $4.2M | Aug 5, 2025 |
| Sonder Futures II, L.P. | Fund | 2024 adv first reported | Early deployment | $44.4M Mar 29, 2024 | 51 | $0 of $225M | Jun 14, 2023 |
| Sonder SPV N Series D, LP | SPV or co-invest vehicle | 2024 form d first sale | Early deployment | unknown | unknown | $1.8M of $1.8M | Apr 17, 2024 |
| Sonder Futures II OS, LP | Fund | 2024 form d first sale | Early deployment | unknown | unknown | $8.5M of $8.5M | Aug 7, 2024 |
| Sonder Spv B, LP | SPV or co-invest vehicle | 2023 form d first sale | Active deployment | $1.1M Mar 29, 2024 | 2 | $1.1M of $1.1M | Sep 11, 2023 |
| Sonder Spv II C, LLC | SPV or co-invest vehicle | 2023 form d first sale | Active deployment | $0 Mar 29, 2024 | 0 | $5.0M of $5.0M | Feb 3, 2023 |
| Sonder Spv N, LP | SPV or co-invest vehicle | 2022 form d first sale | Active deployment | $7.5M Mar 29, 2024 | 97 | $4.9M of $4.9M | Jul 27, 2022 |
| Sonder Spv II a, LLC | SPV or co-invest vehicle | 2022 form d first sale | Active deployment | $2.0M Mar 29, 2024 | 3 | $4.0M of $4.0M | Jan 4, 2023 |
| Sonder Spv II B, LLC | SPV or co-invest vehicle | 2022 form d first sale | Active deployment | $1.6M Mar 29, 2024 | 2 | $1.6M of $1.6M | Mar 31, 2023 |
| Sonder Spv Z, L.P. | SPV or co-invest vehicle | 2021 form d first sale | Mature | $3.3M Mar 29, 2024 | 32 | $3.2M of $3.2M | Aug 5, 2021 |
| Sonder Futures I Partners Fund, L.P. | Fund | 2020 form d first sale | Mature | $12.2M Mar 29, 2024 | 2 | $15.0M of $15.0M | Sep 9, 2020 |
| Sonder Futures I, L.P. | Fund | unknown | Unknown | $67.2M Mar 29, 2024 | 62 | $0 of $80.0M | Jan 30, 2020 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
19 current, 0 departed
Andy Mcgibbon
Board or advisoryOperating Advisor
info@sondercapital.com (published by the subject)FactVenture organization websites (about, team, portfolio, thesis, news pages)
Andy Weiss
Board or advisoryOperating Advisor
Dan Azagury
Board or advisoryClinical Advisor
Grant Heidrich
Board or advisoryFund Advisor
Joe Mandato
Board or advisoryOperating Advisor
Mike Levinthal
Board or advisoryFund Advisor
Roberta Lipson
Board or advisoryOperating Advisor
Fred Moll
General partnerCo-Founder & Partner
Jay Watkins
General partnerCo-Founder & Partner
Marisa Meehan
Investor relationsDirector of Operations & IR
Andy Mcgibbon
Managing partnerManaging Member · since Jan 1, 2020
info@sondercapital.com (published by the subject)FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Frank Thomas Watkins
Managing partnerManaging Member · since May 1, 2018
Frederic Moll
Managing partnerManaging Member · since May 1, 2018
Kate Garrett
Managing partnerManaging Member · since Jan 1, 2020
Kate Garrett
Managing partnerCo-Founder & Managing Partner
Morgan Colby Wood
Managing partnerManaging Member · since May 1, 2018
Deborah Kilpatrick
PartnerPartner
Ori Belson
PrincipalPrincipal
Todd Brinton
Venture partnerVenture Partner
Investments on record
4 edges, 4 companies, 3 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| Cordance Medical | Seed · Seed | lead | unknown | $8.0M | unknown | Nov 24, 2025 | Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) |
| Petal Surgical, Inc. | board seat | unknown · board | Frederic Moll (strongly supported) | unknown | unknown | Aug 29, 2025 | Inference SEC EDGAR Form D data sets (quarterly) |
| EndoQuest Robotics, Inc. | board seat | unknown · board | Frederic Moll (strongly supported) | unknown | unknown | Aug 25, 2025 | Inference SEC EDGAR Form D data sets (quarterly) |
| VerAvanti Inc. | board seat | unknown · board | Frederic Moll (strongly supported) | unknown | unknown | Mar 10, 2025 | Inference SEC EDGAR Form D data sets (quarterly) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
5 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
10 dated events
- Mar 29, 2024Sonder Spv II C, LLC first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund)Fund first reported on Form ADVFundsFactSonder Spv II C, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2024Sonder Spv B, LP first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund), GAV $1,088,889Fund first reported on Form ADVFundsFactSonder Spv B, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2024Sonder Futures II, L.P. first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund), GAV $44,378,223Fund first reported on Form ADVFundsFactSonder Futures II, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2023Sonder Spv II B, LLC first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund), GAV $1,608,325Fund first reported on Form ADVFundsFactSonder Spv II B, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2023Sonder Spv N, LP first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund), GAV $5,143,667Fund first reported on Form ADVFundsFactSonder Spv N, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2023Sonder Spv II a, LLC first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund), GAV $3,999,992Fund first reported on Form ADVFundsFactSonder Spv II a, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Nov 12, 2021Sonder Futures I, L.P. first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund), GAV $105,442,516Fund first reported on Form ADVFundsFactSonder Futures I, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Nov 12, 2021Sonder Spv Z, L.P. first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund), GAV $3,265,345Fund first reported on Form ADVFundsFactSonder Spv Z, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Nov 12, 2021Sonder Futures I Partners Fund, L.P. first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund), GAV $19,855,861Fund first reported on Form ADVFundsFactSonder Futures I Partners Fund, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Nov 12, 2021Sonder Capital Management, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $139M across 12 vehicles
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $139M across 9 vehicles
Evidence
44 observations from 3 sources